Evolutionary Dynamics of Infectious Disease Flashcards
SIR disease example
measles - oscillation, vaccine responsive
SI disease examples
HIV, TB- reach equilibrium, can evade clearance so makes vaccination harder
SIRS disease examples
covid, flu- antigenic diversity, requires this to be considered in vax strategy
why doesn’t measles have issues with antigenic diversity?
the dominant target of immunity (hemagglutinin) is conserved due to structural constraints- it needs to bind to receptors
why does influenza have antigenic diversity?
the major targets for the immune system are outside of the part which is required for binding
what determines R0?
rate of new infections from an infected person * duration of infectiousness
competitive exclusion in the context of R0
strain with a higher R0 will ‘win’, with no difference in virulence or antigenic type
virulence impact on competitiveness
more virulent > less time infected as more likely to die > reduced competitiveness
R0 and virulence
R0 may be maximised at intermediate levels of virulence, as it maximises both transmission rate and transmission duration
example- how did myxoma virus evolve?
convergence towards intermediate levels of virulence (grade 3 on a 1-5 scale) after fully virulent strain was introduced
> same thing happened in australia and europe
how can evolution towards virulence be encouraged?
imperfect vaccination- strains which can overcome the immune system have the advantage
cross-immunity
extent to which immunity to one strain will help when exposed to a second strain- can encourage coexistence if it is low
example of cross-immunity avoidance
B. parapertussis bacteria arising even though B. pertussis was endemic- O antigen on the LPS protects the new species from any immune responses to the old species
what factors might determine if there is coexistence or one species only?
immune memory period, cross-protection, vaccine coverage
example of cases where cross-immunity avoidance has caused issues with our vaccination strategy
strep. pneumoniae- a lot of differentiation of immune targets, so hard to create appropriate vaccines, 90+ capsule types in total with 15 causing most disease